|
H2AFZ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.381300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.705450E-01 |
| Normal-vs-Stage2 |
1.177360E-01 |
| Normal-vs-Stage3 |
2.003800E-04 |
| Normal-vs-Stage4 |
3.714000E-02 |
| Stage1-vs-Stage2 |
3.975000E-01 |
| Stage1-vs-Stage3 |
2.202800E-04 |
| Stage1-vs-Stage4 |
3.834500E-02 |
| Stage2-vs-Stage3 |
1.537240E-01 |
| Stage2-vs-Stage4 |
4.274800E-01 |
| Stage3-vs-Stage4 |
7.566400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.042250E-02 |
| Normal-vs-AfricanAmerican |
6.883800E-03 |
| Normal-vs-Asian |
7.603700E-03 |
| Caucasian-vs-AfricanAmerican |
4.213200E-01 |
| Caucasian-vs-Asian |
1.964630E-01 |
| AfricanAmerican-vs-Asian |
3.329400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.493800E-02 |
| Normal-vs-Female |
1.586330E-04 |
| Male-vs-Female |
5.957300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.713700E-02 |
| Normal-vs-Extreme_Weight |
6.016000E-02 |
| Normal-vs-Obese |
8.721800E-03 |
| Normal-vs-Extreme_Obese |
6.686600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.155600E-01 |
| Normal_Weight-vs-Obese |
8.236600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.126200E-02 |
| Extreme_Weight-vs-Obese |
3.145400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.221560E-01 |
| Obese-vs-Extreme_Obese |
4.309500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.619600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.238600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.338000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.185800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.748000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.245910E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.744400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.063600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.975000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.491200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.022500E-02 |
| Normal-VS-Type2 PRCC |
7.886400E-02 |
| Normal-VS-KIRP CIMP |
4.764000E-03 |
| Normal-VS-Unclassified PRCC |
1.309560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.166600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.477870E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.509600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.013700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.206800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.258240E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.371180E-01 |
| Normal-vs-N1 |
7.793100E-04 |
| Normal-vs-N2 |
3.277100E-03 |
| N0-vs-N1 |
7.480700E-03 |
| N0-vs-N2 |
4.977600E-02 |
| N1-vs-N2 |
6.297400E-01 |
|
|
